Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$128M |
| 2 |
FedEx
FDX
|
+$120M |
| 3 |
Peloton Interactive
PTON
|
+$97.8M |
| 4 |
Newmont
NEM
|
+$78.9M |
| 5 |
Infosys
INFY
|
+$78.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$291M |
| 3 |
Apple
AAPL
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$240M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.85% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 14.74% |
| 4 | Consumer Staples | 10.36% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
INNOVATE Corp
VATE
$107M
| $104K | ﹤0.01% |
3,194
-754
| -19% | -$21K |
|
2152
SITE Centers
SITC
$161M
| $102K | ﹤0.01% |
12,909
-30,851
| -71% | -$215K |
|
|
PFSW
2153
DELISTED
PFSweb, Inc.
PFSW
| $99K | ﹤0.01% |
14,760
| – | – |
|
|
AGTC
2154
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $96K | ﹤0.01% |
23,551
| – | – |
|
2155
Kosmos Energy
KOS
$1.76B
| $92K | ﹤0.01% |
39,103
-175,564
| -82% | -$278K |
|
2156
Tilly's
TLYS
$120M
| $91K | ﹤0.01% |
+11,206
| New | +$84.7K |
|
|
OSG
2157
DELISTED
Overseas Shipholding Group Inc.
OSG
| $91K | ﹤0.01% |
42,594
-16,921
| -28% | -$35.3K |
|
|
BCLI
2158
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $89K | ﹤0.01% |
1,308
-59
| -4% | -$8.04K |
|
2159
Geron
GERN
$977M
| $85K | ﹤0.01% |
53,558
| – | – |
|
2160
Stereotaxis
STXS
$142M
| $83K | ﹤0.01% |
16,358
-17,666
| -52% | -$72.3K |
|
|
SPPI
2161
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $79K | ﹤0.01% |
23,030
| – | – |
|
|
EVFM
2162
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $77K | ﹤0.01% |
2,116
| – | – |
|
|
CLVS
2163
DELISTED
Clovis Oncology, Inc.
CLVS
| $75K | ﹤0.01% |
+15,685
| New | +$79.3K |
|
2164
W&T Offshore
WTI
$592M
| $74K | ﹤0.01% |
+33,960
| New | +$65.5K |
|
2165
DigitalBridge
DBRG
$2.95B
| $73K | ﹤0.01% |
3,779
-17,386
| -82% | -$278K |
|
2166
Ovid Therapeutics
OVID
$547M
| $70K | ﹤0.01% |
30,387
-20,247
| -40% | -$94.4K |
|
2167
Ezcorp Inc
EZPW
$1.98B
| $69K | ﹤0.01% |
14,339
-1,563
| -10% | -$7.86K |
|
|
AUY
2168
DELISTED
Yamana Gold, Inc.
AUY
| $69K | ﹤0.01% |
12,137
-2,074
| -15% | -$11.7K |
|
2169
Nordic American Tanker
NAT
$1.48B
| $68K | ﹤0.01% |
22,911
-66,998
| -75% | -$218K |
|
2170
Ribbon Communications
RBBN
$363M
| $68K | ﹤0.01% |
10,378
-11,091
| -52% | -$58.6K |
|
|
GTT
2171
DELISTED
GTT Communications, Inc.
GTT
| $68K | ﹤0.01% |
+19,114
| New | +$82.6K |
|
|
RVLP
2172
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $66K | ﹤0.01% |
16,026
-54,175
| -77% | -$312K |
|
2173
TherapeuticsMD
TXMD
$23.8M
| $62K | ﹤0.01% |
+1,030
| New | +$70.3K |
|
|
KG
2174
Kestrel Group
KG
$60.3M
| $55K | ﹤0.01% |
1,094
-1,235
| -53% | -$42.4K |
|
2175
Quad
QUAD
$532M
| $50K | ﹤0.01% |
13,216
-77,474
| -85% | -$238K |
|
Similar funds
Cliff Asness's Q4 2020 Portfolio in Review
As of Q4 2020, Cliff Asness held 2,327 positions worth $56.4B, down 4.7% from $59.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cliff Asness withdrew a net $9.06B in Q4 2020, closing 151 positions and reducing 1,279 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Peloton Interactive worth $122M.
- Cliff Asness's largest Q4 2020 buy was Peloton Interactive: 803,242 shares worth $122M.
- Cliff Asness added most to Zoom in Q4 2020, an estimated $128M increase.
- Cliff Asness's biggest Q4 2020 reduction was Biogen, cutting an estimated $309M.
- Cliff Asness fully exited iShares Core S&P 500 ETF in Q4 2020, selling an estimated $291M.
- Cliff Asness's ten largest holdings make up 19% of its $56.4B portfolio in Q4 2020.
- Cliff Asness opened 157 new positions and closed 151 in Q4 2020.
- Cliff Asness's portfolio value fell 4.7% quarter-over-quarter to $56.4B.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.